Form 4 holding
President and CEO, Director
Cyclacel Pharmaceuticals, Inc.
- Security class
- Common Stock
- Shares / value
- 68,658
- Estimated value
- $227,601
- Report date
- 21 Dec 2023
- Price
- $3.32
- Ownership
- Direct
Spiro George Rombotis - President and CEO, Director at Bio Green Med Solution, Inc.
Issuer-level insider activity
- Role
- President and CEO, Director
- Issuer ticker
- BGMS on Nasdaq, BGMSP on OTC
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Spiro George Rombotis since 12 Sep 2025
Reported holdings for Spiro George Rombotis in Bio Green Med Solution, Inc.
Form 4 holding
President and CEO, Director
Cyclacel Pharmaceuticals, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 110,000
- Estimated value
- Report date
- 30 Jun 2023
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
President and CEO, Director
Cyclacel Pharmaceuticals, Inc.
- Security class
- Warrants (right to buy)
- Shares / value
- 6,070
- Estimated value
- Report date
- 21 Dec 2023
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Spiro George Rombotis in Bio Green Med Solution, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.